07-02-2022 | Semaglutide | News
The STEP 6 findings reveal significant weight loss, along with a reduction in abdominal visceral fat, in east Asian people with obesity taking a high dose of semaglutide.
11-01-2022 | Semaglutide | News
Semaglutide 2.4 mg produces substantially more weight loss than liraglutide 3.0 mg in people with overweight or obesity but without diabetes, say the STEP 8 investigators.
07-10-2021 | SGLT2 inhibitors | News
A real-world study shows a reduced risk for heart failure hospitalization, even in people without pre-existing cardiovascular disease, with use of SGLT2 inhibitors versus GLP-1 receptor agonists.
04-06-2022 | ADA 2022 | Conference coverage | News
26-05-2022 | Insulin glargine | News
19-05-2022 | Semaglutide | News
09-05-2022 | Semaglutide | News
07-05-2022 | Semaglutide | Adis Journal Club | Article
03-05-2022 | GLP-1 agonists | Adis Journal Club | Article
08-04-2022 | DUKPC 2022 | Conference coverage | News
05-04-2022 | Medications | At a glance | Article
Get the latest developments in diabetes delivered straight to your inbox